Lancashire and South Cumbria
Formulary
Formulary
15 Anaesthesia
15-02 Bupivacaine
The licensed doses stated may not be appropriate in some settings and expert advice should be sought.
| Bupivacaine and Adrenaline |
|
Formulary
|
| Injection 0.25% / 1:200,000 10mL Injection 0.5% / 1:200,000 10mL |
|
| Bupivacaine Hydrochloride 0.5% with Glucose |
|
Formulary
|
Injection bupivacaine 5mg/mL / glucose 80mg/mL 4mL |
|
|
| Bupivacaine with Fentanyl |
|
Formulary
|
Epidural infusion fentanyl 2micrograms/mL, bupivacaine 0.1% 500mL |
|
Links
Lancashire and South Cumbria Infant Feeding Network - Diagnosis and Management of Milk Allergy and Intolerance Guideline- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA alert: Anaphylaxis risk with chlorhexidine
- MHRA: All medical devices and medicinal products containing chlorhexidine - Risk of anaphylactic reaction due to chlorhexidine allergy
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Chlorhexidine solutions: reminder of the risk of chemical burns in premature infants
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people